| Current Price | $15.85 | Mkt Cap | $335.79M |
|---|---|---|---|
| Open | $16.09 | P/E Ratio | 0.00 |
| Prev. Close | $16.22 | Div. (Yield) | N/A (N/A) |
| Daily Range | $15.80 - $16.31 | Volume | 69,411 |
| 52-Wk Range | $12.65 - $19.62 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- A Forward Look, The Year Ahead - Featured Research on AMAG Pharmaceuticals, Inc. and Akorn, Inc. 2/10/2012 9:00:00 AM -
- SEC charges insider trading in Takeda pharma deal 2/9/2012 11:55:49 AM -
- Market Report -- In Play (AMAG) 2/7/2012 4:34:00 PM -
- AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board 2/7/2012 4:30:00 PM -
- Allos Therapeutics Cut to Neutral - Analyst Blog 1/12/2012 5:15:01 PM
- AMAG Q4 Sales Set to Disappoint - Analyst Blog 1/11/2012 1:15:01 PM
- AMAG's Feraheme Gets Canada Nod - Analyst Blog 12/15/2011 3:00:01 PM
- Allos Continues to Outperform - Analyst Blog 11/25/2011 12:15:01 PM
| Subject | Recs | Author | Date |
|---|




